Related Experiment Video

Updated: Jul 6, 2026

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

Is natalizumab overshooting its rebound?

Robert J Fox, Ludwig Kappos

    Neurology
    |March 26, 2008
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
    06:37

    Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

    Published on: September 15, 2023

    Related Experiment Videos

    Last Updated: Jul 6, 2026

    Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
    09:54

    Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

    Published on: May 22, 2020

    Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
    06:37

    Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

    Published on: September 15, 2023

    Related Concept Videos

    Desensitization and Tachyphylaxis01:20

    Desensitization and Tachyphylaxis

    Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
    Several...
    Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

    Drug Accumulation During Multiple Dosing: Repetitive IV Injections

    Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...

    Articles linked to this work by shared authors, journal, and citation graph.

    Disability accrual in primary and secondary progressive multiple sclerosis.

    Journal of neurology, neurosurgery, and psychiatry·2023

    Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab.

    Neurology(R) neuroimmunology & neuroinflammation·2023

    Assessment of cognitive performance in multiple sclerosis using smartphone-based training games: a feasibility study.

    Journal of neurology·2023

    An investigation of the association between focal damage and global network properties in cognitively impaired and cognitively preserved patients with multiple sclerosis.

    Frontiers in neuroscience·2023

    Personalized maps of T1 relaxometry abnormalities provide correlates of disability in multiple sclerosis patients.

    NeuroImage. Clinical·2023

    Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis.

    Neurology(R) neuroimmunology & neuroinflammation·2023

    Incident Stroke in the United States and Foreign Born Black Individuals.

    Neurology·2026

    Two-Year Retention of Benefits After Paired Vagus Nerve Stimulation in Stroke: Follow-Up of the VNS-REHAB Randomized Clinical Trial.

    Neurology·2026

    Legal Protections to Mitigate Discrimination due to Neurodegenerative Biomarker Status.

    Neurology·2026

    Orexin, Sleep, and Cognition in Alzheimer Disease: Non-REM Oscillatory Activity and Neural Resilience.

    Neurology·2026

    Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases.

    Neurology·2026

    Association of Plasma Neurofilament Light Chain With Diagnostic Classification in a Neuromuscular Referral Cohort: A Cross-Sectional Study.

    Neurology·2026

    Programmable DNA nanowires mediated dispersion-to-localization catalytic hairpin assembly for high-contrast miRNA detection and imaging.

    Biosensors & bioelectronics·2026

    Enhanced production of bacterial nanocellulose by <i>Bacillus subtilis</i> using combined mutagenesis and response surface optimization approaches.

    Preparative biochemistry & biotechnology·2026

    On-demand growth of semiconductor heterostructures guided by physics-informed machine learning.

    Science advances·2026

    Click'n ROPISA: One-Pot Synthesis of Ultrabright Fluorescent Nanoparticles Made of Polypeptides.

    Angewandte Chemie (International ed. in English)·2026

    Self-driving lab for the data-driven design of single-chain polymer nanoparticles.

    Cell press blue·2026

    Highly Controlled Nanostructured CuO Photocathodes.

    ACS applied nano materials·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us